Emily Birnbaum
@ebirnbaum.bsky.social
180 followers
270 following
3 posts
Postdoc at Mount Sinai | Neuroscience PhD from CUNY Graduate Center working on drug discovery for Alzheimer’s disease | Weill Cornell CTSC TL1 award recipient
Posts
Media
Videos
Starter Packs
Reposted by Emily Birnbaum
Reposted by Emily Birnbaum
Reposted by Emily Birnbaum
Reposted by Emily Birnbaum
Usha Lee McFarling
@usha.bsky.social
· Jan 26
Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?
Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.
www.statnews.com
Reposted by Emily Birnbaum
Dave Levitan
@davelevitan.bsky.social
· Jan 25
Reposted by Emily Birnbaum
BWJones
@bwjones.bsky.social
· Jan 22
Reposted by Emily Birnbaum
Itai Yanai
@itaiyanai.bsky.social
· Nov 24
Emily Birnbaum
@ebirnbaum.bsky.social
· Nov 21
BT-11 repurposing potential for Alzheimer's disease and insights into its mode of actions https://www.biorxiv.org/content/10.1101/2024.10.29.620882v1
BT-11 repurposing potential for Alzheimer's disease and insights into its mode of actions https://www.biorxiv.org/content/10.1101/2024.10.29.620882v1
Neuroinflammation is a key pathological hallmark of Alzheimer's disease (AD). Investigational and FD
www.biorxiv.org